Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Seeking Rural Health Funds, States Mull Limiting Their Powers No Photo Available

Mark Payne

A $50 billion federal fund meant to prop up rural healthcare providers is prompting some policymakers to rethink laws requiring medica... (more story)

Biopharma Co.'s Down-Round IPO May Signal More To Come No Photo Available

Yeji Jesse Lee

Biotech Eikon Therapeutics is preparing for a down-round IPO that attorneys and analysts say may serve as a bellwether for how certain... (more story)

Abortion Access Org. Launches With Challenge To Ark. Ban No Photo Available

Dan McKay

In recent days, a newly formed abortion-rights legal group filed a constitutional challenge to anti-abortion laws in Arkansas, joining... (more story)